publication venue for
- Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.. 4. 1998
- Molecular therapy for cancer.. 4 Suppl 1. 1998
- Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients.. 4. 1998
- Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.. 3 Suppl 1. 1997
- Rational interleukin-2 therapy.. 3 Suppl 1. 1997
- Adult medulloblastoma: an analysis of survival and prognostic factors.. 3. 1997
- Factors influencing survival after gamma knife radiosurgery for patients with single and multiple brain metastases.. 2. 1996
- Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.. 2. 1996
- The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery.. 2. 1996
- Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.. 1. 1995
- The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.. 1. 1995
- Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo.. 1. 1995
- Positron emission tomography (PET)--measured biochemical response to radiotherapy of laryngeal tumors.. 3. 1997
- ras Mutation: does it have clinical import?. 3. 1997
- 'Casodex': defining the role of antiandrogens.. 3. 1997
- Neoadjuvant therapy of esophageal cancer.. 3. 1997
- A comparison of prostate cancer treatments: are therapeutic implications justified?. 3. 1997
- Cancer-testis antigens: targets for cancer immunotherapy. 1999
- Primary central nervous system lymphoma: curable without toxicity? 1996
- Monitoring responses to antiangiogenic agents using noninvasive imaging tests. 1999